Cargando…
Study of some potential biomarkers in Egyptian hepatitis C virus patients in relation to liver disease progression and HCC
BACKGROUND: Egypt has the greatest prevalence of hepatitis C worldwide according to the WHO reports, accounting for 13% of the global HCV infections. HCV is a substantial precursor for fibrosis, cirrhosis, and hepatocellular carcinoma. This study aimed to investigate the potential relevance of some...
Autores principales: | Baraka, Kholoud, Abozahra, Rania R., Badr, Eman, Abdelhamid, Sarah M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552374/ https://www.ncbi.nlm.nih.gov/pubmed/37798688 http://dx.doi.org/10.1186/s12885-023-11420-1 |
Ejemplares similares
-
Identifying Different Mutation Sites Leading to Resistance to the Direct-Acting Antiviral (DAA) Sofosbuvir in Hepatitis C Virus Patients from Egypt
por: Shoun, Aly Atef, et al.
Publicado: (2022) -
Genotyping and molecular investigation of plasmid-mediated carbapenem resistant clinical Klebsiella pneumoniae isolates in Egypt
por: Baraka, Kholoud, et al.
Publicado: (2023) -
Investigation of the protective and therapeutic effects of Lactobacillus casei and Saccharomyces cerevisiae in a breast cancer mouse model
por: Baraka, Kholoud, et al.
Publicado: (2022) -
Prevalence of the colistin resistance gene MCR-1 in colistin-resistant Klebsiella pneumoniae in Egypt
por: Abozahra, Rania, et al.
Publicado: (2023) -
TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis
por: Nomair, Azhar Mohamed, et al.
Publicado: (2021)